Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

3.52
Delayed Data
As of Jul 22
 +0.01 / +0.28%
Today’s Change
2.58
Today|||52-Week Range
6.38
-0.56%
Year-to-Date
The 3 Most Dangerous High-Yield Dividend Stocks
Jul 19 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close3.51
Today’s open3.49
Day’s range3.48 - 3.57
Volume632,570
Average volume (3 months)1,577,623
Market cap$581.2M
Dividend yield5.68%
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+9.14%
Earnings growth (this year)-73.76%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.01%
P/E ratio1.9
Price/Sales0.99
Price/Book0.83

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-0.10-0.99%
DVAXDynavax Technologies...+0.01+0.07%
HRTXHeron Therapeutics I...+0.46+2.84%
CLVSClovis Oncology Inc-0.35-2.41%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.08
Annual revenue (last year)$585.1M
Annual profit (last year)$332.8M
Net profit margin56.88%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

Partner Offers

Search for Jobs